The detection of fungal elements and their characterization in patient specimens provides fundamental information. Culture-based methods, though often slow, may yield the specific etiological agent, and may allow susceptibility testing to be performed. Proper collection and transportation of the specimen is essential. Particularly, sterile materials are important for diagnosis of invasive fungal infections.
Therefore, culture and direct microscopy should be performed on all suitable clinical specimens when fungal disease is suspected. Numerous different media for culturing and identifying fungi are available, and those important for diagnosing mycoses as well as the most important staining methods for direct microcopy are described.
Key wordsMedia Specimen processing Preanalytic aspects Microscopy Staining methods
- 5.Willinger B, Kurzai, Kienzl O (2014) Diagnostics of fungal infections. In: Kurzai O (ed) Human fungal pathogens. The mycota XII, 2nd edn. Springer, Heidelberg, Berlin, pp 244–247Google Scholar
- 7.Larone DH (2011) Medically important fungi. A guide to identification. ASM Press, Washington DC, USAGoogle Scholar
- 8.Clinical and Laboratory Standards Institute (2012) Principles and procedures for detection of fungi in clinical specimens—direct examination and culture; approved guideline, CLSI document M54-A. Clinical and Laboratory Standards Institute, Villanova, PAGoogle Scholar
- 9.Scognamiglio T, Zinchuk R, Gumpeni P, Larone DH (2010) Comparison of inhibitory mould agar to Sabouraud dextrose agar as a primary medium or isolation of fungi. J Clin Microbiol 48:1924–1925Google Scholar
- 15.www.eucast.org : EUCAST DEFINITIVE DOCUMENT E.DEF 7.3. Method for the determination of broth dilution minimum Inhibitory concentrations of antifungal agents for yeasts.
- 16.Arendrup MC, Guinea J, Cuenca-Estrella M, Meletiadis J, Mouton JW, Lagrou K, Howard SJ, The Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST) (2008) EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin Microbiol Infect 14:398–405CrossRefGoogle Scholar
- 17.Clinical and Laboratory Standards Institute (2004) Method for antifungal disk diffusion susceptibility testing of yeasts: approved guideline. CLSI Document M44-A2. Clinical and Laboratory Standards Institute, Wayne, PAGoogle Scholar
- 18.Clinical and Laboratory Standards Institute (2009) Zone diameter interpretative standards, corresponding minimal inhibitory concentration (MIC) interpretative breakpoints, and quality control limits for anti-fungal disk diffusion susceptibility testing of yeasts; informational supplement, 3rd edn., CLSI document M44-S3. Clinical and Laboratory Standards Institute, Villanova, PAGoogle Scholar
- 19.Clinical and Laboratory Standards Institute (2010) Reference method for antifungal disk diffusion testing of non-dermatophyte filamentous fungi; approved guideline. CLSI document M51-A. Clinical and Laboratory Standards Institute, Villanova, PAGoogle Scholar
- 20.Clinical and Laboratory Standards Institute (2010) Performance standards for antifungal disk diffusion testing of non-dermatophyte filamentous fungi: informational supplement. CLSI document M51-S1. Clinical and Laboratory Standards Institute, Villanova, PAGoogle Scholar
- 21.Kauffman CA, Fisherack JF, Sobel D, Newman CA (2011) Candida urinary tract infections—diagnosis. Clin Infect Dis 52(S6):S452–S456Google Scholar